Prospective Observational Study on the Management of Patients With Relapsed or Refractory Follicular Lymphoma (OLYMPE)
NCT02316613
·
clinicaltrials.gov ↗
COMPLETED
Status
260
Enrollment
INDUSTRY
Sponsor class
Conditions
Follicular Lymphoma
Interventions
DRUG:
Rituximab
Sponsor
Hoffmann-La Roche